Published in Cancer Weekly, December 22nd, 1997
Enhanced outpatient care also appears to be as safe as conventional BMT, J. Rizzo and colleagues from Johns Hopkins University told attendees at the 39th annual meeting of the American Society of Hematology held December 5-9, 1997, in San Diego, California.
BMT traditionally has been performed during lengthy and expensive inpatient hospitalization. The study, conducted at Johns Hopkins Oncology Center in Baltimore, Maryland, provided...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.